M&As this week: JW Pharmaceutical, Lonza, Karo Intressenter
JW Pharmaceutical has acquired a 25% stake in Argonaut Therapeutics through a $2.6m investment. This move makes JW Pharmaceutical the second…
JW Pharmaceutical has acquired a 25% stake in Argonaut Therapeutics through a $2.6m investment. This move makes JW Pharmaceutical the second…
Canadian company Datinvest International (Datinvest) has signed an agreement to purchase all the outstanding shares and share capital issued by…
Indian pharmaceutical company Cipla plans to issue non-convertible debentures or bonds through a public offering or a private placement to…
US-based healthcare company Eli Lilly and Company has agreed to acquire AurKa Pharma Inc. Eli Lilly will purchase all shares of…
GlaxoSmithKline Plc (GSK) has issued 1.25% international bonds due May 2026 in a public offering to raise €1bn ($1.19bn). The…
Indian bio-pharmaceuticals developer Strides Shasun has signed an agreement with Apotex to merge with the latter’s Australian subsidiary, Apotex. A…
Indian biopharmaceutical company MannKind has agreed to sign a marketing and distribution agreement with Cipla for the inhaled insulin drug,…
Canadian oral drug delivery company IntelGenx Technologies plans to issue 300 units priced at $10,000 a unit in a private…
United Therapeutics Corporation has agreed to acquire SteadyMed for $216m. United Therapeutics will purchase SteadyMed for $4.46 a share in…
US-based biotechnology company CTD Holdings has completed issuing 20,000 units of series B convertible preferred stock for the development of its…